Methyl 2-[1-[3-(4-ethylsulfonylphenyl)propanoyl]spiro[2H-indole-3,1'-cyclopentane]-5-yl]-4-fluorobenzoate
C31H32FNO5S — CID 158750619
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 2-[1-[3-(4-ethylsulfonylphenyl)propanoyl]spiro[2H-indole-3,1'-cyclopentane]-5-yl]-4-fluorobenzoate
Methyl 2-[1-[3-(4-ethylsulfonylphenyl)propanoyl]spiro[2H-indole-3,1'-cyclopentane]-5-yl]-4-fluorobenzoate (PubChem CID 158750619) has the molecular formula C31H32FNO5S and a molecular weight of 549.66 g/mol. Its IUPAC name is methyl 2-[1-[3-(4-ethylsulfonylphenyl)propanoyl]spiro[2H-indole-3,1'-cyclopentane]-5-yl]-4-fluorobenzoate.
Molecular Properties
| Compound Name | Methyl 2-[1-[3-(4-ethylsulfonylphenyl)propanoyl]spiro[2H-indole-3,1'-cyclopentane]-5-yl]-4-fluorobenzoate |
|---|---|
| PubChem CID | 158750619 |
| Molecular Formula | C31H32FNO5S |
| Molecular Weight | 549.66 g/mol |
| Exact Mass | 549.20 |
| IUPAC Name | methyl 2-[1-[3-(4-ethylsulfonylphenyl)propanoyl]spiro[2H-indole-3,1'-cyclopentane]-5-yl]-4-fluorobenzoate |
| SMILES | CCS(=O)(=O)c1ccc(CCC(=O)N2CC3(CCCC3)c3cc(-c4cc(F)ccc4C(=O)OC)ccc32)cc1 |
| InChI | InChI=1S/C31H32FNO5S/c1-3-39(36,37)24-11-6-21(7-12-24)8-15-29(34)33-20-31(16-4-5-17-31)27-18-22(9-14-28(27)33)26-19-23(32)10-13-25(26)30(35)38-2/h6-7,9-14,18-19H,3-5,8,15-17,20H2,1-2H3 |
| InChIKey | INKWFMGNOKFALZ-UHFFFAOYSA-N |
| XLogP | 5.86 |
| TPSA | 80.75 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 549.66 |
| LogP ≤ 5 | 5.86 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158750619 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.